AbbVie Ltd
Date updated: 2026-04-19
TOTAL PRODUCT APPROVED: 2
Overview
Product Registered
Categories
Type of Products
Analysis
Product Holder
| Product holder name | Product count |
|---|---|
| 2 |
Product count2
Rows per page:
1–1 of 1
Analysis
Product API
| Ingredient (API) name | Product count |
|---|---|
| 2 |
Product count2
Rows per page:
1–1 of 1
Listing
Registered Product
| Product name | Product Reg. no | Type | Product Holder | Manufacturer | Importer | Registration Status |
|---|---|---|---|---|---|---|
| Lynparza 100 mg Film-Coated Tablets | MAL19106011ACRZ | NEW CHEMICAL ENTITY | ASTRAZENECA SDN. BHD. | AbbVie Ltd | ASTRAZENECA SDN. BHD. | PRODUCT APPROVED |
| Lynparza 150 mg Film-Coated Tablets | MAL19106013ACRZ | NEW CHEMICAL ENTITY | ASTRAZENECA SDN. BHD. | AbbVie Ltd | ASTRAZENECA SDN. BHD. | PRODUCT APPROVED |
Lynparza 100 mg Film-Coated Tablets
Product Reg. noMAL19106011ACRZ
TypeNEW CHEMICAL ENTITY
Product HolderASTRAZENECA SDN. BHD.
ManufacturerAbbVie Ltd
ImporterASTRAZENECA SDN. BHD.
Registration StatusPRODUCT APPROVED
Lynparza 150 mg Film-Coated Tablets
Product Reg. noMAL19106013ACRZ
TypeNEW CHEMICAL ENTITY
Product HolderASTRAZENECA SDN. BHD.
ManufacturerAbbVie Ltd
ImporterASTRAZENECA SDN. BHD.
Registration StatusPRODUCT APPROVED
Rows per page:
1–2 of 2